"Anxiolysis" means the diminution or elimination of anxiety.
"Enteral" means any method for the introduction of pharmacological agents, including oral, sublingual, rectal or any other method which relies upon absorption through the gastrointestinal tract or oral mucosa and introduction through the nasal passages or any other mucous membrane.
"Enteral sedation with single or multiple pharmacological agents" means the administering, dispensing or prescribing of one or more pharmacological agents to be used concurrently or sequentially for the purposes of causing anxiolysis and a depressed level of consciousness, but not a loss of consciousness. For purposes of this section, pharmacological agents shall include any non-parenteral agent, and shall exclude any agent introduced by intravenous, intramuscular, subcutaneous, submucosal, or inhalation routes, including nitrous oxide inhalation analgesia.
N.J. Admin. Code § 13:30-8.4
See: 32 N.J.R. 215(a), 32 N.J.R. 1221(a).
New Rule, R.2005 d.304, effective 9/6/2005.
See: 36 N.J.R. 3629(a), 37 N.J.R. 3432(a).
Amended by R.2011 d.041, effective 2/7/2011.
See: 42 N.J.R. 2217(a), 43 N.J.R. 310(a).
In (b), (c), and (e), substituted "No" for "As of July 1, 2006, no".